Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Change in Receivables (2021 - 2025)

Core Scientific's Change in Receivables history spans 5 years, with the latest figure at -$6000.0 for Q1 2025.

  • For Q1 2025, Change in Receivables fell 105.66% year-over-year to -$6000.0; the TTM value through Mar 2025 reached -$112000.0, down 111.99%, while the annual FY2023 figure was $767000.0, 376.9% up from the prior year.
  • Change in Receivables for Q1 2025 was -$6000.0 at Core Scientific, up from -$106000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $9.4 million in Q2 2021 and bottomed at -$9.4 million in Q3 2021.
  • The 5-year median for Change in Receivables is $42000.0 (2022), against an average of $527000.0.
  • The largest annual shift saw Change in Receivables skyrocketed 311.93% in 2023 before it plummeted 378.95% in 2024.
  • A 5-year view of Change in Receivables shows it stood at $780000.0 in 2021, then crashed by 211.79% to -$872000.0 in 2022, then skyrocketed by 87.61% to -$108000.0 in 2023, then grew by 1.85% to -$106000.0 in 2024, then surged by 94.34% to -$6000.0 in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Change in Receivables are -$6000.0 (Q1 2025), -$106000.0 (Q2 2024), and $106000.0 (Q1 2024).